Internal Medicine, Interventional Cardiology · Thibodaux, LA
NPI
1093712028
Since 2005
Specialty
Internal Medicine, Interventional Cardiology
Code 207RI0011X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
1320 Martin Luther King Dr
Thibodaux, LA, 70301
Phone (985) 446-2021
Groups this clinician bills Medicare through
Medicare paid, 2024
$638K
9,449 services
Medicare patients, 2024
583
Average age 75
Drug cost, 2024
$3.0M
18,045 prescriptions
Company payments, 2025
$1,702
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mohammed S Rais was code 99214 (office e&m - established), 1,027 times for 461 patients. In total Mohammed S Rais billed 9,449 services in 123 codes, and Medicare paid $638K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-02-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,027 | 461 | $92.90 | $95K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 950 | 443 | $12.83 | $12K |
| 93000 Electrocardiogram | Office | 770 | 496 | $10.12 | $7,793 |
| 80053 Clinical Chemistry | Office | 600 | 360 | $10.32 | $6,190 |
| 80061 Clinical Chemistry | Office | 528 | 349 | $13.06 | $6,896 |
| 84443 Clinical Chemistry | Office | 475 | 334 | $16.41 | $7,794 |
| 85025 Blood Count | Office | 441 | 311 | $7.56 | $3,333 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 345 | 42 | $46.87 | $16K |
| 93306 Echocardiography (TTE/TEE) | Office | 319 | 312 | $122.85 | $39K |
| 99454 E&M - Miscellaneous | Office | 290 | 38 | $32.17 | $9,331 |
| J2785 Injection, regadenoson, 0.1 mg | Office | 257 | 65 | $5.08 | $1,304 |
| 99457 E&M - Miscellaneous | Office | 254 | 38 | $35.74 | $9,079 |
| 83036 Blood Count | Office | 236 | 176 | $9.46 | $2,233 |
| 84436 Clinical Chemistry | Office | 233 | 223 | $6.72 | $1,565 |
| 84479 Clinical Chemistry | Office | 231 | 220 | $6.33 | $1,462 |
By year: 2022 $566K for 20,547 services; 2023 $596K for 24,383 services; 2024 $638K for 9,449 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80053 Clinical Chemistry | 600 | 360 | $10.32 | $6,190 |
| 80061 Clinical Chemistry | 528 | 349 | $13.06 | $6,896 |
| 84443 Clinical Chemistry | 475 | 334 | $16.41 | $7,794 |
| 85025 Blood Count | 441 | 311 | $7.56 | $3,333 |
| 83036 Blood Count | 236 | 176 | $9.46 | $2,233 |
| 84436 Clinical Chemistry | 233 | 223 | $6.72 | $1,565 |
| 84479 Clinical Chemistry | 231 | 220 | $6.33 | $1,462 |
| 85610 Clinical Chemistry | 119 | 14 | $4.20 | $500 |
| 80048 Clinical Chemistry | 90 | 75 | $8.29 | $746 |
| 85027 Blood Count | 68 | 56 | $6.34 | $431 |
Medicare prescription drug claims, 2024
In 2024, the drug Mohammed S Rais prescribed most often to Medicare patients was Atorvastatin Calcium, with 1,545 prescriptions and refills. In total Mohammed S Rais wrote 18,045 Medicare prescriptions that cost $3.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 1,545 | 3,843 | 428 | $12K |
| Metoprolol Succinate Generic | 1,097 | 2,521 | 294 | $13K |
| Clopidogrel Clopidogrel Bisulfate | 1,090 | 2,777 | 302 | $8,966 |
| Lisinopril Generic | 1,002 | 2,410 | 291 | $4,870 |
| Rosuvastatin Calcium Generic | 951 | 2,359 | 267 | $8,731 |
| Nifedipine Er Nifedipine | 895 | 2,015 | 228 | $20K |
| Eliquis Apixaban | 721 | 1,145 | 159 | $665K |
| Carvedilol Generic | 680 | 1,570 | 191 | $3,789 |
| Pantoprazole Sodium Generic | 546 | 1,173 | 150 | $4,824 |
| Hydrochlorothiazide Generic | 541 | 1,264 | 165 | $2,039 |
| Ezetimibe Generic | 493 | 1,125 | 129 | $7,608 |
| Amlodipine Besylate Generic | 464 | 1,078 | 124 | $2,145 |
| Metoprolol Tartrate Generic | 439 | 1,050 | 111 | $2,481 |
| Pravastatin Sodium Generic | 418 | 997 | 108 | $5,804 |
| Entresto Sacubitril/Valsartan | 415 | 637 | 86 | $428K |
Brand drugs: 3,071 claims; generic drugs: 14,974 claims; opioid claims: 17.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mohammed S Rais $1,702 ($1,702 in general payments such as food, travel and fees) from 18 companies. The largest payer was Novartis Pharmaceuticals Corporation with $304.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 21 | $304 |
| AngioDynamics, Inc. ANGO | 6 | $255 |
| Merck Sharp & Dohme LLC MRK | 11 | $190 |
| Novo Nordisk Inc NVO | 3 | $162 |
| Actelion Pharmaceuticals US, Inc. JNJ | 1 | $132 |
| Pfizer Inc. PFE | 5 | $88.4 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $81.64 |
| Regeneron Healthcare Solutions, Inc. REGN | 4 | $78.93 |
| E.R. Squibb & Sons, L.L.C. BMY | 4 | $70.25 |
| Alnylam Pharmaceuticals Inc. ALNY | 2 | $68.85 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.